Readcrest Capital AG: Management Board Projects 2026 Adjusted EBITDA Growth

• Readcrest Capital AG forecasts an adjusted EBITDA of EUR 8-9 million for 2026, mainly from Grosvenor Health and Social Care minus German project contributions.
• The sale of the UK care home business has led to a revised group structure, with Grosvenor remaining as a key revenue and cash flow contributor.
• The company is expanding into value-oriented real estate investments, focusing on residential projects in high-growth regions of Germany.
• Adjusted EBITDA is an unaudited metric, calculated as operating profit plus depreciation and amortization, adjusted for non-recurring items and excluding sold care homes.
• The forecast reflects the company's strategic shift and growth focus following asset sales and new investments.
• The announcement was made on June 7, 2026, and is classified as inside information under EU regulations.

Exklusiv für wallstreetONLINE-Leser Eröffnen Sie bis zum 31.07.2026 ein Depot bei Smartbroker+ und erhalten Sie einen Anteil Ihrer Lieblingsaktie aus unserer Auswahl im Wert von 50 Euro geschenkt!

Schreibe Deinen Kommentar